KALA BIO, INC. Accrued Liabilities, Current
KALA BIO, INC. (KALA) had Accrued Liabilities, Current of $4.50 million as of 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2024-11-12
- 2024-09-30: Accrued Liabilities, Current $4.50M.
- 2024-06-30: Accrued Liabilities, Current $3.92M.
- 2024-03-31: Accrued Liabilities, Current $4.81M.
- 2023-12-31: Accrued Liabilities, Current $6.02M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2024-09-30 | $4.50M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $3.92M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $4.81M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $6.02M 10-Q · filed 2024-11-12 | |
| 2023-09-30 | $6.26M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $4.90M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $5.08M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $8.91M 10-K · filed 2024-03-29 | |
| 2022-09-30 | $25.37M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $18.31M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $21.24M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $20.99M 10-K · filed 2023-03-03 | |
| 2021-09-30 | $19.46M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $21.25M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $15.15M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $18.97M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $15.85M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $13.97M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $14.71M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $20.93M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $14.55M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $12.88M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $10.34M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $11.10M 10-K · filed 2020-02-12 | |
| 2018-09-30 | $7.97M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $5.15M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $3.70M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $6.61M 10-K · filed 2019-03-12 | $6.59M 10-K · filed 2018-04-02 |
| 2017-09-30 | $3.94M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $4.30M 10-Q · filed 2017-08-31 | |
| 2016-12-31 | $3.99M 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |